 Neurohumoral activation congestive heart failure article evidence congestive heart failure plasma norepinephrine concentration due tissue clearance substance marked increase sympathetic nerve activity data sympathetic activation activation renin-angiotensin system plasma level vasopressin degree congestive heart failure become manifest clear studies sympathetic renin-angiotensin systems normal asymptomatic congestive heart failure condition New York Heart Association class II evidence activation compensatory responsible number adverse cardiovascular effects negative relationship event survival article inability plasma level atrial natriuretic peptide congestive heart failure adverse effects neurohumoral activation variable influence drug treatment phenomenon impossible heart transplantation major factor increased sympathetic activity surgical intervention impairment arterial baroreflex